Approvals/TGA/EMEND IV fosaprepitant 150mg (as fosaprepitant dimeglumine) powder for injection vial

Approved

STANDARD

EMEND IV fosaprepitant 150mg (as fosaprepitant dimeglumine) powder for injection vial

Merck Sharp & Dohme (Australia) Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 4767c2e47df80c5e
Product Name: EMEND IV fosaprepitant 150mg (as fosaprepitant dimeglumine) powder for injection vial
Artg Id: 167061
Artg Name: EMEND IV fosaprepitant 150mg (as fosaprepitant dimeglumine) powder for injection vial
Sponsor: Merck Sharp & Dohme (Australia) Pty Ltd
Company Detail Path: /organization/merck-sharp-and-dohme-australia-pty-ltd
Artg Date: 2011-03-18
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-CMI-04089-3
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-PI-04088-3

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

4767c2e47df80c5e

Type

Standard